Literature DB >> 27165610

Distinct roles for the complement regulators factor H and Crry in protection of the kidney from injury.

Jennifer Laskowski1, Brandon Renner1, Moglie Le Quintrec2, Sarah Panzer3, Jonathan P Hannan1, Danica Ljubanovic4, Marieta M Ruseva5, Dorin-Bogdan Borza6, Alexandra H Antonioli1, Matthew C Pickering5, V Michael Holers1, Joshua M Thurman7.   

Abstract

Mutations in the complement regulatory proteins are associated with several different diseases. Although these mutations cause dysregulated alternative pathway activation throughout the body, the kidneys are the most common site of injury. The susceptibility of the kidney to alternative pathway-mediated injury may be due to limited expression of complement regulatory proteins on several tissue surfaces within the kidney. To examine the roles of the complement regulatory proteins factor H and Crry in protecting distinct renal surfaces from alternative pathway mediated injury, we generated mice with targeted deletions of the genes for both proteins. Surprisingly, mice with combined genetic deletions of factor H and Crry developed significantly milder renal injury than mice deficient in only factor H. Deficiency of both factor H and Crry was associated with C3 deposition at multiple locations within the kidney, but glomerular C3 deposition was lower than that in factor H alone deficient mice. Thus, factor H and Crry are critical for regulating complement activation at distinct anatomic sites within the kidney. However, widespread activation of the alternative pathway reduces injury by depleting the pool of C3 available at any 1 location.
Copyright © 2016 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  complement; glomerulonephritis; inflammation

Mesh:

Substances:

Year:  2016        PMID: 27165610      PMCID: PMC4912413          DOI: 10.1016/j.kint.2016.02.036

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  54 in total

Review 1.  Complement regulators and inhibitory proteins.

Authors:  Peter F Zipfel; Christine Skerka
Journal:  Nat Rev Immunol       Date:  2009-09-04       Impact factor: 53.106

Review 2.  Atypical hemolytic-uremic syndrome.

Authors:  Marina Noris; Giuseppe Remuzzi
Journal:  N Engl J Med       Date:  2009-10-22       Impact factor: 91.245

3.  C3 glomerulopathy: clinicopathologic features and predictors of outcome.

Authors:  Nicholas R Medjeral-Thomas; Michelle M O'Shaughnessy; John A O'Regan; Carol Traynor; Michael Flanagan; Limy Wong; Chia Wei Teoh; Atif Awan; Mary Waldron; Tom Cairns; Patrick O'Kelly; Anthony M Dorman; Matthew C Pickering; Peter J Conlon; H Terence Cook
Journal:  Clin J Am Soc Nephrol       Date:  2013-10-31       Impact factor: 8.237

4.  Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.

Authors:  Aude Servais; Véronique Frémeaux-Bacchi; Moglie Lequintrec; Rémi Salomon; Jacques Blouin; Bertrand Knebelmann; Jean-Pierre Grünfeld; Philippe Lesavre; Laure-Hélène Noël; Fadi Fakhouri
Journal:  J Med Genet       Date:  2006-10-03       Impact factor: 6.318

5.  Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B.

Authors:  H Watanabe; G Garnier; A Circolo; R A Wetsel; P Ruiz; V M Holers; S A Boackle; H R Colten; G S Gilkeson
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

6.  Sudan black B reduces autofluorescence in murine renal tissue.

Authors:  Yan Sun; Hong Yu; Dong Zheng; Qi Cao; Ya Wang; David Harris; Yiping Wang
Journal:  Arch Pathol Lab Med       Date:  2011-10       Impact factor: 5.534

7.  Causes of alternative pathway dysregulation in dense deposit disease.

Authors:  Yuzhou Zhang; Nicole C Meyer; Kai Wang; Carla Nishimura; Kathy Frees; Michael Jones; Louis M Katz; Sanjeev Sethi; Richard J H Smith
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-05       Impact factor: 8.237

8.  C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation.

Authors:  Agustín Tortajada; Hugo Yébenes; Cynthia Abarrategui-Garrido; Jaouad Anter; Jesús M García-Fernández; Rubén Martínez-Barricarte; María Alba-Domínguez; Talat H Malik; Rafael Bedoya; Rocío Cabrera Pérez; Margarita López Trascasa; Matthew C Pickering; Claire L Harris; Pilar Sánchez-Corral; Oscar Llorca; Santiago Rodríguez de Córdoba
Journal:  J Clin Invest       Date:  2013-06       Impact factor: 14.808

9.  Localization of the complement regulatory proteins in the normal human kidney.

Authors:  S Ichida; Y Yuzawa; H Okada; K Yoshioka; S Matsuo
Journal:  Kidney Int       Date:  1994-07       Impact factor: 10.612

10.  Factor H facilitates the clearance of GBM bound iC3b by controlling C3 activation in fluid phase.

Authors:  Danielle Paixão-Cavalcante; Steven Hanson; Marina Botto; H Terence Cook; Matthew C Pickering
Journal:  Mol Immunol       Date:  2009-05-02       Impact factor: 4.407

View more
  13 in total

1.  Complement factor H-deficient mice develop spontaneous hepatic tumors.

Authors:  Jennifer Laskowski; Brandon Renner; Matthew C Pickering; Natalie J Serkova; Peter M Smith-Jones; Eric T Clambey; Raphael A Nemenoff; Joshua M Thurman
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

2.  The Plethora of Angiotensin-Converting Enzyme-Processed Peptides in Mouse Plasma.

Authors:  Margarita Semis; Gabriel B Gugiu; Ellen A Bernstein; Kenneth E Bernstein; Markus Kalkum
Journal:  Anal Chem       Date:  2019-05-07       Impact factor: 6.986

3.  Modulation of the Alternative Pathway of Complement by Murine Factor H-Related Proteins.

Authors:  Alexandra H Antonioli; Janice White; Frances Crawford; Brandon Renner; Kevin J Marchbank; Jonathan P Hannan; Joshua M Thurman; Philippa Marrack; V Michael Holers
Journal:  J Immunol       Date:  2017-11-29       Impact factor: 5.422

4.  Pericytes and immune cells contribute to complement activation in tubulointerstitial fibrosis.

Authors:  Sandhya Xavier; Ranjit K Sahu; Susan G Landes; Jing Yu; Ronald P Taylor; Srinivas Ayyadevara; Judit Megyesi; William B Stallcup; Jeremy S Duffield; Edimara S Reis; John D Lambris; Didier Portilla
Journal:  Am J Physiol Renal Physiol       Date:  2017-01-04

Review 5.  All Things Complement.

Authors:  Joshua M Thurman; Carla M Nester
Journal:  Clin J Am Soc Nephrol       Date:  2016-06-23       Impact factor: 8.237

6.  Complement factor H protects mice from ischemic acute kidney injury but is not critical for controlling complement activation by glomerular IgM.

Authors:  Lindsey Goetz; Jennifer Laskowski; Brandon Renner; Matthew C Pickering; Liudmila Kulik; Jelena Klawitter; Erik Stites; Uwe Christians; Johan van der Vlag; Kameswaran Ravichandran; V Michael Holers; Joshua M Thurman
Journal:  Eur J Immunol       Date:  2018-02-22       Impact factor: 5.532

7.  Alternative Pathway Is Essential for Glomerular Complement Activation and Proteinuria in a Mouse Model of Membranous Nephropathy.

Authors:  Wentian Luo; Florina Olaru; Jeffrey H Miner; Laurence H Beck; Johan van der Vlag; Joshua M Thurman; Dorin-Bogdan Borza
Journal:  Front Immunol       Date:  2018-06-22       Impact factor: 7.561

8.  Mesenchymal Stem Cells Control Complement C5 Activation by Factor H in Lupus Nephritis.

Authors:  Haijun Ma; Chang Liu; Bingyu Shi; Zhuoya Zhang; Ruihai Feng; Minghao Guo; Liwei Lu; Songtao Shi; Xiang Gao; Wanjun Chen; Lingyun Sun
Journal:  EBioMedicine       Date:  2018-06-07       Impact factor: 8.143

9.  Murine Factor H Co-Produced in Yeast With Protein Disulfide Isomerase Ameliorated C3 Dysregulation in Factor H-Deficient Mice.

Authors:  Heather Kerr; Andrew P Herbert; Elisavet Makou; Dariusz Abramczyk; Talat H Malik; Hannah Lomax-Browne; Yi Yang; Isabel Y Pappworth; Harriet Denton; Anna Richards; Kevin J Marchbank; Matthew C Pickering; Paul N Barlow
Journal:  Front Immunol       Date:  2021-05-12       Impact factor: 7.561

Review 10.  Complements are involved in alcoholic fatty liver disease, hepatitis and fibrosis.

Authors:  Cheng-Jie Lin; Zhi-Gao Hu; Guan-Dou Yuan; Biao Lei; Song-Qing He
Journal:  World J Hepatol       Date:  2018-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.